MIRM
Mirum Pharmaceuticals Inc Earnings
$88.09
Earnings Summary
Revenue | $148.93Mn |
Net Profits | $-5.73Mn |
Net Profit Margins | -3.85% |
Mirum Pharmaceuticals Inc’s revenue jumped 49.81% since last year same period to $148.93Mn in the Q4 2025. On a quarterly growth basis, Mirum Pharmaceuticals Inc has generated 11.97% jump in its revenue since last 3-months.
Mirum Pharmaceuticals Inc’s net profit jumped 75.91% since last year same period to $-5.73Mn in the Q4 2025. On a quarterly growth basis, Mirum Pharmaceuticals Inc has generated -297.25% fall in its net profits since last 3-months.
Mirum Pharmaceuticals Inc’s net profit margin jumped 83.92% since last year same period to -3.85% in the Q4 2025. On a quarterly growth basis, Mirum Pharmaceuticals Inc has generated -276.16% fall in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
EPS Estimate Current Quarter | -0.05 |
EPS Estimate Current Year | -0.05 |
Mirum Pharmaceuticals Inc’s earning per share (EPS) estimates for the current quarter stand at -0.05 - a 67.6% jump from last quarter’s estimates.
Mirum Pharmaceuticals Inc’s earning per share (EPS) estimates for the current year stand at -0.05.
Key Ratios
Earning Per Share (EPS) | -0.12 |
Mirum Pharmaceuticals Inc’s earning per share (EPS) jumped 75.51% since last year same period to -0.12 in the Q4 2025. This indicates that the Mirum Pharmaceuticals Inc has generated 75.51% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2025-08-06 | -0.33 | -0.12 | 63.64% |
2025-11-04 | -0.15 | 0.05 | 133.33% |
2026-02-25 | -0.05 | -0.12 | -146.91% |
2025-05-07 | -0.48 | -0.3 | 37.5% |
